Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Leukaemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00027547
What this trial is testing

Combination Chemotherapy and Total-Body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Study completedNCT04178798
What this trial is testing

Study to Investigate the Use of Acalabrutinib in the Treatment of Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia- Binet Staging System
PETHEMA Foundation 22
Large-scale testing (Phase 3)Enrolling By InvitationNCT07651163
What this trial is testing

Comparing the Efficacy of LDA, LHAA, and LA Regimens in Young Adults With Intermediate- and High-Risk Acute Myeloid Leukemia Eligible for Intensive Chemotherapy

Who this might be right for
Acute Myeloid Leukemia (AML)Lisaftoclax
First Affiliated Hospital of Zhejiang University 450
Testing effectiveness (Phase 2)Study completedNCT02294552
What this trial is testing

Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoid LeukemiaLymphoma+3 more
Ivan S Moiseev 200
Large-scale testing (Phase 3)Looking for participantsNCT06810791
What this trial is testing

HVA vs IA/DA or VA in the Treatment of ND HR-AML

Who this might be right for
Newly Diagnosed Acute Myeloid Leukemia With High Risk
Nanfang Hospital, Southern Medical University 876
Testing effectiveness (Phase 2)Study completedNCT02506959
What this trial is testing

Panobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma

Who this might be right for
Plasma Cell LeukemiaPlasmacytomaRecurrent Plasma Cell Myeloma+1 more
M.D. Anderson Cancer Center 83
Early research (Phase 1)Study completedNCT00003079
What this trial is testing

Bryostatin 1 and High Dose Cytarabine in Treating Patients With Refractory or Relapsed Leukemia or Lymphoma

Who this might be right for
LeukemiaLymphoma
Virginia Commonwealth University 30
Early research (Phase 1)Study completedNCT00940524
What this trial is testing

Induction Therapy With Cytarabine, High-Dose Mitoxantrone and Dasatinib for Patients With Philadelphia-Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia

Who this might be right for
LeukemiaAcute Lymphoblastic Leukemia
Memorial Sloan Kettering Cancer Center 7
Testing effectiveness (Phase 2)Ended earlyNCT00003113
What this trial is testing

Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas

Who this might be right for
Lymphoma
Case Comprehensive Cancer Center 6
Testing effectiveness (Phase 2)Temporarily pausedNCT04278768
What this trial is testing

Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndrome
Curis, Inc. 366
Not applicableLooking for participantsNCT06537726
What this trial is testing

Breath Analysis for the Detection of Invasive Fungal Infections

Who this might be right for
LeukemiaLeukemia, MyeloidLeukemia, Lymphoblastic+4 more
University of Zurich 130
Large-scale testing (Phase 3)UnknownNCT03256071
What this trial is testing

Low Dose Decitabine + Modified BUCY Conditioning Regimen for High Risk Acute Myeloid Leukemia Undergoing Allo-HSCT

Who this might be right for
Acute Myeloid LeukemiaAllogeneic Hematopoietic Stem Cell TransplantationConditioning
The First Affiliated Hospital of Soochow University 90
Testing effectiveness (Phase 2)Study completedNCT01236144
What this trial is testing

A Trial to Establish the Feasibility of Combining Either the Tyrosine Kinase Inhibitor AC220,CXCR4 Inhibitor Plerixafor or HSP90 Inhibitor Ganetespib With Chemotherapy in Older Patients With Acute Myeloid Leukaemia and High Risk Myelodysplastic Syndrome.

Who this might be right for
Acute Myeloid LeukaemiaHigh Risk Myelodysplastic Syndrome
Cardiff University 113
Testing effectiveness (Phase 2)Study completedNCT00060255
What this trial is testing

High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors

Who this might be right for
Breast CancerLeukemiaLymphoma+4 more
Roswell Park Cancer Institute 451
Testing effectiveness (Phase 2)Study completedNCT03207555
What this trial is testing

Ibrutinib as Early Therapy in Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Malignant Neoplasms Stated as Primary Lymphoid HaematopoieticChronic Lymphocytic LeukemiaSmall Lymphocytic Leukemia
M.D. Anderson Cancer Center 23
Testing effectiveness (Phase 2)Ended earlyNCT00374296
What this trial is testing

MGCD0103 in Elderly Patients With Previously Untreated AML/High Risk MDS or Adults With Relapsed/Refractory Disease

Who this might be right for
Myelogenous Leukemia, AcuteMyelodysplastic Syndromes
Mirati Therapeutics Inc. 35
Large-scale testing (Phase 3)Study completedNCT02301156
What this trial is testing

Ublituximab in Combination With Ibrutinib Versus Ibrutinib Alone in Participants With Previously Treated High-Risk Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia
TG Therapeutics, Inc. 126
Testing effectiveness (Phase 2)UnknownNCT04541277
What this trial is testing

Combined Inhibition of PD-1 and DNA Hypomethylating Agent +/- Chemotherapy in High-risk AML or Elderly Patients With AML Who Are Unfit for Intensive Chemotherapy

Who this might be right for
Acute Myeloid Leukemia, in Relapsed or RefractoryAcute Myeloid Leukemia, Elderly, UnfitAcute Myeloid Leukemia With Positive Minimal Residual Disease
Chinese PLA General Hospital 55
Testing effectiveness (Phase 2)Study completedNCT00339196
What this trial is testing

5-azacytidine Valproic Acid and ATRA in AML and High Risk MDS

Who this might be right for
Acute Myelogenous Leukaemia (AML)Myelodysplastic Syndrome (MDS)
Assistance Publique - Hôpitaux de Paris 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06438796
What this trial is testing

Blinatumomab Maintenance After Allo-HSCT

Who this might be right for
High Risk Acute Lymphoblastic Leukemia
Ruijin Hospital 59
Next Page